1,802
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Inhibitors of TLR-4, NF-κB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells

, , , , , & show all
Pages 133-140 | Received 28 Mar 2012, Accepted 02 Jun 2012, Published online: 25 Jul 2012

References

  • Akira, S., Uematsu, S., Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell 124:783–801.
  • Bennett, B. L., Sasaki, D. T., Murray, B. W., O’Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., Anderson, D. W. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681–13686.
  • Broad, A., Jones, D. E., Kirby, J. A. 2006. Toll-like receptor (TLR) response tolerance: A key physiological “damage limitation” effect and an important potential opportunity for therapy. Curr. Med.Chem. 13:2487–2502.
  • Christopher, J. A., Avitabile, B. G., Bamborough, P., Champigny, A. C., Cutler, G. J., Dyos, S. L., Grace, K. G., Kerns, J. K., Kitson, J. D., Mellor, G. W., Morey, J. V., Morse, M. A., O’Malley, C. F., Patel, C. B., Probst, N., Rumsey, W., Smith, C. A., Wilson, M. J. 2007. The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKKα and IKKβ kinases. Bioorg. Med. Chem. Lett. 17:3972–3977.
  • Dokladny, K., Lobb, R., Wharton, W., Ma, T. Y., Moseley, P. L. 2010. LPS-induced cytokine levels are repressed by elevated expression of HSP70 in rats: Possible role of NF-κB. Cell Stress Chaperon. 15:153–163.
  • Gao, J. J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., Murphy, W. J. 1998. Autocrine/paracrine IFNγ mediates the lipopolysaccharide-induced activation of transcription factor Stat1 in mouse macrophages: Pivotal role of Stat1 in induction of the inducible nitric oxide synthase gene. J. Immunol. 161:4803–4810.
  • Glushkova, O. V., Novoselova, T. V., Khrenov, M. O., Parfenyuk, S. B., Lunin, S. M., Fesenko, E. E., Novoselova, E. G. 2010. Role of heat shock protein hsp90 in formation of protective reactions in acute toxic stress. Biochemistry (Moscow) 75:702–707.
  • Haddad, J. J., Abdel-Karim, N. E. 2011. NF-κB Cellular and molecular regulatory mechanisms and pathways: Therapeutic pattern or pseudo-regulation. Cell. Immunol. 271:5–14.
  • Ishii, K. J., Uematsu, S., Akira, S. 2006. ‘Toll’ gates for future immunotherapy. Curr. Pharm. Des. 12:4135–4142.
  • Kawai, T., Akira, S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317–337.
  • Krishnan, J., Selvarajoo, K., Tsuchiya, M., Lee, G., Choi, S. 2007. Toll-like receptor signal transduction. Exp. Mol. Med. 39:421–438.
  • Loiarro, M., Ruggiero, V., Sette, C. 2010. Targeting TLR/IL-1R signalling in human diseases. Mediat. Inflamm. Available online at: http://www.hindawi.com/journals/mi/2010/674363/. Accessed 10 May 2012
  • Luo, J. L, Kamata, H., Karin, M. 2005. IKK/NFкB signaling: Balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115:2625–2632.
  • Macdonald, J., Galley, H. F., Webster, N. R. 2003. Oxidative stress and gene expression in sepsis. Brit. J. Anaesth. 90:221–232.
  • Medvedev, A. E., Kopydlowski, K. M., Vogel, S. N. 2000. Expression chemokine, and toll-like receptor 2 and 4 gene macrophages: Deregulation of cytokine, transduction in endotoxin-tolerated mouse inhibition of lipopolysaccharide-induced signal. J. Immunol. 164:5564–5574.
  • Medzhitov, R., Preston-Hurlburt, P. Jr., andJaneway, C. A. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397.
  • Nakamura, L. T., Wu-Hsieh, B. A., Howard, D. H. 1994. Recombinant murine γ-interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62:680–684.
  • Novoselova, E. G., Glushkova, O. V., Cherenkov, D. A., Parfenyuk, S. B., Novoselova, T. V., Lunin, S. M., Khrenov, M. O., Guzhova, I. V., Margulis, B. A., Fesenko, E. E. 2006. Production of heat shock proteins, cytokines, and nitric oxide in toxic stress. Biochemistry (Moscow) 71:376–383.
  • Novoselova, E. G., Lunin, S. M., Novoselova, T. V., Khrenov, M. O., Glushkova, O. V., Avkhacheva, N. V., Safronova, V. G., Fesenko, E. E. 2009. Naturally occurring anti-oxidant nutrients reduce inflammatory response in mice. Eur. J. Pharmacol. 615:234–240.
  • O’Neill, L. A., Bryant, C. E., Doyle, S. L. 2009. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharm. Rev. 61:177–197.
  • Papa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., Franzoso, G. 2006. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and diseases. Cell Death Differ. 13:712–729.
  • Papa, S., Zazzeroni, F., Pham, C. G., Bubici, C., Franzoso, G. 2004. Linking JNK signaling to NF-кB: A key to survival. J. Cell Sci. 117:5197–5208.
  • Ratajczak-Wrona, W., Jablonska, E., Garley, M., Jablonski, J., Radziwon, P. 2011. Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: The role of JNK signalling pathway. Acta Pathol. Microbiol. Immunol. Scand. 119:431–441.
  • Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., Ulevitch, R. J. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429–1431.
  • Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., Kimoto, M. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777–1782.
  • Strober, W. 1997. Trypan blue exclusion test of cell viability. Curr. Prot. Immunol. 21:A.3B.1–A.3B.2.
  • Thiefes, A., Wolter, S., Mushinski, J. F., Hoffmann, E., Dittrich-Breiholz, O., Graue, N., Dorrie, A., Schneider, H., Wirth, D., Luckow, B., Resch, K., Kracht, M. 2005. Simultaneous blockade of NF-κB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis target genes. J. Biol. Chem. 280:27728–27741.
  • Towbin, H., Staehelin, T., Gordon, J. 1976. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some application. Proc. Natl. Acad. Sci. USA 76:4350–4354.
  • Triantafilou, M., Sawyer, D., Nor, A., Vakakis, E., Triantafilou, K. 2008. Cell surface molecular chaperones as endogenous modulators of the innate immune response. Novartis Found. Symp. 291:74–79.
  • Tuyt, L. M., Dokter, W. H., Birkenkamp, K., Koopmans, S. B., Lummen, C., Kruijer, W., Vellenga, E. 1999. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-κB-dependent IL-6 expression in human monocytes. J. Immunol. 162:4893–4902.
  • Vega, V. L., de Maio, A. 2003. Geldanamycin treatment ameliorates the response to LPS in murine macrophages by decreasing CD14 surface expression. Mol. Biol. Cell. 14:764–773.
  • Wittebole, X., Castanares-Zapatero, D., Laterre, P. F. 2010. Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediat. Inflamm. Available online at: http://www.hindawi.com/ journals/mi/2010/568396, accessed 2 March 2010.
  • Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433.
  • Zeytun, A., Chaudhary, A., Pardington, P., Cary, R., Gupta, G. 2010. Induction of cytokines and chemokines by Toll-like receptor signaling: strategies for control of inflammation. Crit. Rev. Immunol. 30:53–67.
  • Zhu, J., Mohan, C. 2010. Toll-like receptor signaling pathways - therapeutic opportunities. Mediat. Inflamm. Available online at: http://www.hindawi.com/journals/mi/2010/781235/, accessed 20 July 2010.
  • Zughaier, S. M., Zimmer, S. M., Datta, A., Carlson, R. W., Stephens, D. S. 2005. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 73:2940–2950.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.